AI-assisted confocal imaging to guide removal of basal cell carcinoma

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this observational project, surgeons will collect ex vivo confocal laser scanning microscopy (CLSM) images from tissue excised during routine basal cell carcinoma surgeries. An AI algorithm will be developed to classify image regions as tumor, inflammatory, or non-tumor tissue and to provide automated annotations in near real time. The goal is to integrate AI output into the intraoperative workflow to offer immediate feedback without altering standard surgical care. Collected AI predictions will be compared with standard histopathology and surgeon assessment to measure accuracy and potential workflow advantages.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with Basal Cell Carcinoma

Exclusion Criteria:

* Patient unable to consent

Where it's running

• Clinic and Policlinic of Dermatology and Allergy, LMU Munich
  Munich, Bavaria, Germany Recruiting

Study contacts

• Study coordinator: Maximilian Deußing, Dr.
• Email: maximilian.deussing@med.uni-muenchen.de
• Phone: +4989440056010

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• AI-based risk and subtype prediction for basal cell carcinoma using dermoscopic images

  A retrospective study tests an artificial intelligence model to classify basal cell carcinoma as low- or high-risk and to predict histopathological subtypes from archived dermoscopic images.

  Recruiting Istanbul Training and Research Hospital · Istanbul, Istanbul · NCT07677124

• Methionine-Reduced Diet in Solid Tumors (early-phase)

  A small pilot study will test whether a methionine-reduced diet can change blood levels in adults with various solid tumors who are receiving standard cancer therapy.

  Recruiting Early Phase 1 University of California, Irvine · Orange, California · NCT07628634

• In-home cancer treatment with remote specialist support for patients in the Florida Panhandle

  This program will try giving standard cancer treatments at home to people living in the Florida Panhandle and nearby areas to see if they prefer it and have better treatment satisfaction.

  Recruiting Phase 2 Mayo Clinic · Jacksonville, Florida · NCT07285044

• Vitamin D and light therapy to boost skin cancer response before surgery

  This study tests whether giving Vitamin D or a placebo around the time of a light-based treatment (PDT) can help boost skin cancer treatment before Mohs surgery or ED&C in adults with basal cell or squamous cell carcinoma.

  Recruiting Case Comprehensive Cancer Center · Cleveland, Ohio · NCT07241585

• Using line-field confocal OCT to map Mohs surgery margins for basal cell carcinoma

  This tests whether line-field confocal optical coherence tomography (LC-OCT) can noninvasively show the edges of basal cell carcinomas in adults scheduled for Mohs surgery.

  Recruiting Roswell Park Cancer Institute · Buffalo, New York · NCT07182240

• Neoadjuvant Opdualag (nivolumab + relatlimab) versus nivolumab for resectable high-risk basal cell carcinoma

  This trial tests whether adding relatlimab to nivolumab before surgery helps people with resectable high‑risk basal cell carcinoma shrink tumors and improve surgical outcomes.

  Recruiting at 3 sites Phase 2 University of California, San Diego · Irvine, California and 2 other locations · NCT06624475

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.